Eliem Therapeutics Inc
ELYM
Get informed when a big investor buys or sells
+ FollowMarket Cap$342.68M
Close$
$3.44
32.7% downside
Current Fair Value
32.7% downsideOvervalued by 32.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $342.68 Million |
|---|---|
| Enterprise Value | $334.80 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.88 |
| Beta | -0.38 |
| Outstanding Shares | 68,207,313 |
Return
| Return on Equity | -35.65% |
|---|---|
| Return on Assets | -34.65% |
| Return on Invested Capital | -41.86% |
Valuation & Multiples
| P/E Ratio | -14.16 |
|---|---|
| PEG | 41.69 |
| Price to Sales | - |
| Price to Book Ratio | 2.56 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.39 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 45.92%▼ 19.72% |
|---|---|
| Total Invested | $157.45M▲ 75.49% |
| Investors Holding | 64▼ 3.00% |
ESG Score
No data
About Eliem Therapeutics Inc
2,021 employees